您的位置: 专家智库 > >

国家自然科学基金(81202731)

作品数:4 被引量:48H指数:4
相关作者:陈川申定珠邢三丽陈久林顾闻更多>>
相关机构:上海市中医老年医学研究所上海中医药大学更多>>
发文基金:国家自然科学基金上海市卫生局科研基金上海市卫生局中医药科研基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 4篇中文期刊文章

领域

  • 4篇医药卫生

主题

  • 2篇动脉
  • 2篇动脉粥样硬化
  • 1篇蛋白
  • 1篇蛋白激酶
  • 1篇蛋白激酶CΒ
  • 1篇血脂
  • 1篇炎症
  • 1篇炎症因子
  • 1篇氧化应激
  • 1篇治心
  • 1篇生理病理
  • 1篇溯本求源
  • 1篇五脏
  • 1篇五脏相关
  • 1篇经络
  • 1篇颈动脉
  • 1篇颈动脉粥样硬...
  • 1篇激酶
  • 1篇P66SHC
  • 1篇PCSK9

机构

  • 3篇上海市中医老...
  • 2篇上海中医药大...

作者

  • 3篇陈川
  • 2篇邢三丽
  • 2篇申定珠
  • 1篇陈久林
  • 1篇顾闻

传媒

  • 1篇新中医
  • 1篇中国生物化学...
  • 1篇Chines...
  • 1篇中华中医药学...

年份

  • 1篇2020
  • 2篇2014
  • 1篇2013
4 条 记 录,以下是 1-4
排序方式:
Effect of Quercetin on Atherosclerosis Based on Expressions of ABCA1, LXR-α and PCSK9 in ApoE-/- Mice被引量:16
2020年
Objective:To investigate the effect of quercetin on ATP binding cassette transporter A1(ABCA1),liver X receptor(LXR),and proprotein convertase subtilisin/kexin type 9(PCSK9)expressions in apoE-knockout(ApoE-/-)mice.Methods:The high-fat diet-induced atherosclerosis(AS)in ApoE-/-mice was established.Thirtysix mice were divided into 3 groups using random number table method:model group(n=12),quercetin group(n=12),and atorvastatin group(n=12),with C57BL/6J mice of the same strain and age as the control group(n=12).Quercetin group and atorvastatin group were administrated with quercetin and atorvastatin by oral gavage,with doses of 12.5 and 4 mg/(kg・d),respectively.Animals in the control and model groups were given an equal volume of distilled water by oral gavage once per day for a total of 12 weeks.Western blot and immunohistochemical methods were employed to determine the aortic ABCA1,LXR-a and PCSK9 protein expressi on.En zyme linked imm uno sorbent assay method was used to detect the expressi on of serum total cholesterol(TC),triglyceride(TG),high density lipoprotein-cholesterol(HDL-C),low density lipoproteincholesterol(LDL-C),tumor necrosis factor-a(TNF-a),interleukin-6(IL-6),and IL-10,combined with tissue pathological exami nation.Results:ApoE-/-mice fed with a high-fat diet had no table atherosclerosis lesions,with reduced ABCA1,LXR-a and IL-10 levels(all P<0.01),elevated PCSK9,TNF-a and IL-6 expression,and increased TC and LDL-C con tents(all P<0.01).After querceti n in terventi on,the areas of AS plaques and the expressions of PCSK9,TNF-a and IL-6 were significantly reduced(all P<0.01),while the expressions of ABCA1 and LXR-a were increased significantly(all P<0.01).Conclusion:Quercetin effectively interfered with AS development by regulating the expressions of ABCA1,LXR-a and PCSK9 in ApoE,mice.
LI Shan-shanCAO HuiSHEN Ding-zhuCHEN ChuanXING San-liDOU Fang-fangJIA Qing-ling
关键词:QUERCETINATHEROSCLEROSIS
首参颗粒对颈动脉粥样硬化患者血脂及炎症因子的影响被引量:24
2014年
目的:观察首参颗粒对颈动脉粥样硬化患者外周血总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)及炎症因子C反应蛋白(CRP)、白细胞介素6(IL-6)的影响。方法:156例颈动脉粥样硬化患者随机分为中药组83例和西药组73例。中药组服用首参颗粒,西药组口服普法他汀片,疗程均为6个月。于治疗前、治疗后3、6个月分别观察血脂及CRP、IL-6的变化。结果:中药组治疗后TG、TC/HDL-C比值较治疗前均下降明显(P<0.05或P<0.01),HDL-C值上升明显(P<0.01),与西药组同期比较差异无统计学意义(P>0.05);中药组治疗后CRP、IL-6表达较治疗前均明显下降(P<0.01),与西药组同期比较差异无统计学意义(P>0.05)。结论:首参颗粒可改善颈动脉粥样硬化患者脂质代谢紊乱,降低CRP、IL-6水平进而有效干预治疗颈动脉粥样硬化病变。
申定珠陈川陈久林邢三丽
关键词:颈动脉粥样硬化血脂CRPIL-6
氧化应激下的p66^(Shc)调控作用被引量:4
2014年
氧化应激产生的过量活性氧簇(reactive oxygen species,ROS)可通过分子毒性作用或相关信号通路影响相关病理生理学过程.p66Shc是Shc蛋白家族的重要成员之一.氧化应激下p66Shc能被蛋白激酶Cβ(protein kinase Cβ,PKCβ)、Jun氨基末端激酶(Jun N-terminal kinase,JNK)和p53等激活,促进线粒体产生ROS.本文将对氧化应激下p66Shc的作用以及调控其作用的信号转导机制做一综述.
顾闻陈川
关键词:P66SHC氧化应激
溯本求源 补中寓通——从肾治心溯源被引量:4
2013年
从五行相生、经络相连及五脏相关生理病理角度,对肾与心两脏的相互关系进行阐述,并以从"肾"论治动脉粥样硬化、冠心病为例,为从肾治心法提供佐证。
申定珠邢三丽陈川
关键词:五脏相关经络生理病理动脉粥样硬化
共1页<1>
聚类工具0